Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 19.11.2020Eli Lilly Nederland B.V. (LIL-NL-2)3137BABASAGLAR 100 jednotiek/ml injekčný roztok v náhradnej náplni (sol inj 10x3 ml (náplň skl.))1.3.2021Z
 16.12.2021TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)13444Abelcet lipid complex (dis inf 10x20 ml (liek.inj.skl.))1.1.2022R
 5.4.2024Biosimilar Collaborations Ireland Limited (BTT)7461DAbevmy 25 mg/ml koncentrát na infúzny roztok (con inf 1x16 ml/400 mg (liek.inj.skl.))5.4.2024O
 7.3.2024Biosimilar Collaborations Ireland Limited (BTT)7461DAbevmy 25 mg/ml koncentrát na infúzny roztok (con inf 1x16 ml/400 mg (liek.inj.skl.))5.3.2024R
 13.5.2021Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)92340ABILIFY 10 mg orodispergovateľné tablety (tbl oro 28x1x10 mg (perf.jednod.bli.Alu/Alu))13.5.2021Z
 13.5.2021Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)92343ABILIFY 15 mg orodispergovateľné tablety (tbl oro 28x1x15 mg (perf.jednod.bli.Alu/Alu))13.5.2021R
 13.5.2021Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)92343ABILIFY 15 mg orodispergovateľné tablety (tbl oro 28x1x15 mg (perf.jednod.bli.Alu/Alu))13.5.2021Z
 13.5.2021Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)40783ABILIFY 15 mg tablety (tbl 28x1x15 mg (perf.jednod.bli.Alu/Alu))15.3.2021Z
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))12.2.2024O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))25.10.2023R
 15.2.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))16.2.2023R
 17.3.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))15.3.2023O
 13.3.2024G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))4.3.2024O
 18.1.2024G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))18.1.2024R
 9.5.2023medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8030DAbiraterone medac 500 mg filmom obalené tablety (tbl flm 56x500 mg (blis.PVC/PVDC/Al))11.5.2023U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To